- Home
- TMC vs FATE Comparison
TMC vs FATE Comparison
Compare TMC & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMC | FATE |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 260.0M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TMC | FATE |
|---|---|---|
| Price | $2.25 | $1.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $10.90 | $5.74 |
| AVG Volume (30 Days) | ★ 5.1M | 1.1M |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 232.00 | 29.88 |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | ★ $6,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.16 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.25 | $0.95 |
| 52 Week High | $10.05 | $3.23 |
Technical Indicators
Market Signals| Indicator | TMC | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 32.90 | 39.49 |
| Support Level | N/A | $1.78 |
| Resistance Level | $2.97 | $2.19 |
| Average True Range (ATR) | 0.22 | 0.13 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 30.19 | 22.62 |
Price Performance
Historical ComparisonAbout TMC TMC the metals company Inc.
TMC The Metals Co Inc is a deep seabed minerals developer focused on the collection, processing and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ), approximately 1,500 miles (or 2,400 kilometers) south-west of San Diego, California. The company operates as a single operating and reportable segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.